Clinical Research
Along with normal clinical service, wide range of clinical trials also provided in our center
We are actively recruiting patient to participate in the following clinical trials
Please send referral letter to medicaloncology@hku.hk if interested
Phase 1 Study
Protocol Number
Protocol Title
Experimental agent
Principle Investigator
A001
A Phase 1, first-in-human study of ARB202, bispecific antibody to CDH17 and CD3 in advanced gastrointestinal malignancies
ARB202
RLY-4008-101
A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With Intrahepatic Cholangiocarcinoma (ICC) and Other Advanced Solid Tumors
RLY-4008
BA3021-001
A phase 1/2 dose escalation and dose expansion study of BA3021 alone and in combination with nivolumab in patients with advanced solid tumors
BA3021
+/-
nivolumab
NEI01-20001
A 2-part, First-in-patient, Open-label, Dose-escalation and Expansion Cohort Study of NEI-01 as Monotherapy in Patients With Advanced Solid Tumors or Relapsed/Refractory Acute Myeloid Leukemia
NEI-01
4003.1
A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors
HBM4003